Oruka Therapeutics, Inc. (ORKA)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch ORKA
See up to 3 months of ORKA. The 7-day demo opens the 1M and 3M ranges and puts ORKA on your watchlist.
Start 7-day demoLatest ORKA insider trades
About Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. files with the SEC under CIK 0000907654 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ORKA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 45 | 216,895 | $20.80M |
| Grant or award | 2 | 120,000 | |
| Option exercise | 32 | 420,916 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ORKA insider transactions (Form 4)
13056 Form 4 filings on record, the earliest from Nov 21, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Arjun Agarwal - Officer | Option exercise | Common Stock | 8,541 | $12.50 | $107K | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 1,458 | $34.39 | $50K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 5,741 | $80.03 footnote F2 | $459K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,100 | $80.76 footnote F3 | $170K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 1,958 | $81.86 footnote F4 | $160K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 200 | $82.84 footnote F5 | $17K | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 8,541 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 1,458 | $0.00 | - | |
| ||||||
 Lawrence Otto Klein - Officer | Option exercise | Common Stock | 25,000 | $7.80 | $195K | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 16,246 | $83.40 footnote F2 | $1.35M | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 8,554 | $84.03 footnote F3 | $719K | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 200 | $84.78 footnote F4 | $17K | |
| Lawrence Otto Klein - Officer | Option exercise | Employee Warrant (right to buy) | 25,000 | $0.00 | - | |
| ||||||
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 533 | $95.75 | $51K | |
| Paul T. Quinlan - Officer | Option exercise | Common Stock | 10,000 | $7.80 | $78K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 2,900 | $92.37 footnote F2 | $268K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 3,832 | $93.32 footnote F3 | $358K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 601 | $94.44 footnote F4 | $57K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 2,667 | $95.31 footnote F5 | $254K | |
| Paul T. Quinlan - Officer | Option exercise | Employee Warrant (right to buy) | 10,000 | $0.00 | - | |
| ||||||
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $6.84 | $24K | |
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $7.80 | $27K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 2,384 | $91.10 footnote F2 | $217K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 3,150 | $92.03 footnote F3 | $290K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 1,366 | $92.99 footnote F4 | $127K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 100 | $94.22 footnote F5 | $9K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 947 | $95.71 | $91K | |
| Joana Goncalves - Officer | Option exercise | Employee Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Joana Goncalves - Officer | Option exercise | Employee Warrant (right to buy) | 3,500 | $0.00 | - | |
| ||||||
| Arjun Agarwal - Officer | Option exercise | Common Stock | 8,000 | $12.50 | $100K | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 1,459 | $34.39 | $50K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 3,000 | $91.11 footnote F2 | $273K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 4,051 | $92.41 footnote F3 | $374K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,208 | $93.26 footnote F4 | $206K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 200 | $94.02 footnote F5 | $19K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 560 | $95.71 | $54K | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 1,459 | $0.00 | - | |
| ||||||
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 2,452 | $95.71 | $235K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 1,039 | $95.71 | $99K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 906 | $95.71 | $87K | |
| Laura Lee Sandler - Officer | Option exercise | Common Stock | 5,000 | $7.80 | $39K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 1,000 | $91.05 footnote F2 | $91K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 4,000 | $92.01 footnote F3 | $368K | |
| Laura Lee Sandler - Officer | Option exercise | Employee Warrant (right to buy) | 5,000 | $0.00 | - | |
| ||||||
| Lawrence Otto Klein - Officer | Option exercise | Common Stock | 75,000 | $7.80 | $585K | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 6,604 | $90.79 footnote F2 | $600K | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 63,596 | $91.90 footnote F3 | $5.84M | |
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 4,800 | $92.44 footnote F4 | $444K | |
| Lawrence Otto Klein - Officer | Option exercise | Employee Warrant (right to buy) | 75,000 | $0.00 | - | |
| ||||||
 Larry Todd Edwards - Officer | Grant or award | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Larry Todd Edwards - Officer | Grant or award | Employee Stock Option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $6.84 | $24K | |
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $7.80 | $27K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 900 | $109.65 footnote F2 | $99K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 300 | $110.52 footnote F3 | $33K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 3,320 | $112.01 footnote F4 | $372K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 2,480 | $112.56 footnote F5 | $279K | |
| Joana Goncalves - Officer | Option exercise | Employee Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Joana Goncalves - Officer | Option exercise | Employee Warrant (right to buy) | 3,500 | $0.00 | - | |
| ||||||
| Paul T. Quinlan - Officer | Option exercise | Common Stock | 10,000 | $7.80 | $78K | |
| Paul T. Quinlan - Officer | Option exercise | Common Stock | 42,000 | $12.50 | $525K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 3,630 | $106.05 footnote F2 | $385K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 10,434 | $107.14 footnote F3 | $1.12M | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 14,696 | $107.97 footnote F4 | $1.59M | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 10,200 | $109.11 footnote F5 | $1.11M | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 9,193 | $110.00 footnote F6 | $1.01M | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 3,847 | $111.14 footnote F7 | $428K | |
| Paul T. Quinlan - Officer | Option exercise | Employee Warrant (right to buy) | 10,000 | $0.00 | - | |
| Paul T. Quinlan - Officer | Option exercise | Employee Stock Option (right to buy) | 42,000 | $0.00 | - | |
| ||||||
| Arjun Agarwal - Officer | Option exercise | Common Stock | 8,542 | $12.50 | $107K | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 1,458 | $34.39 | $50K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,100 | $104.67 footnote F2 | $220K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,132 | $105.57 footnote F3 | $225K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 1,268 | $106.63 footnote F4 | $135K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,142 | $107.71 footnote F5 | $231K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 2,358 | $108.46 footnote F6 | $256K | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 8,542 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 1,458 | $0.00 | - | |
| ||||||
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $6.84 | $24K | |
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $7.80 | $27K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 400 | $84.37 footnote F2 | $34K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 2,497 | $85.86 footnote F3 | $214K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 3,803 | $86.68 footnote F4 | $330K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 300 | $87.25 footnote F5 | $26K | |
| Joana Goncalves - Officer | Option exercise | Employee Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Joana Goncalves - Officer | Option exercise | Employee Warrant (right to buy) | 3,500 | $0.00 | - | |
| ||||||
| Arjun Agarwal - Officer | Option exercise | Common Stock | 8,541 | $12.50 | $107K | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 1,458 | $34.39 | $50K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 300 | $83.07 footnote F2 | $25K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 3,743 | $84.26 footnote F3 | $315K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 5,656 | $84.90 footnote F4 | $480K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 300 | $85.63 footnote F5 | $26K | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 8,541 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 1,458 | $0.00 | - | |
| ||||||
| Fairmount Funds Management LLC - Director | Other | Common Stock | 3,553,410 | - footnote F1 | - | |
| Fairmount Funds Management LLC - Director | Open-market sale | Common Stock | 3,553,410 | $84.43 | $300.01M | |
| Fairmount Funds Management LLC - Director | Other | Series B Preferred Stock | 42,641 | $0.00 | - | |
| ||||||
| Laura Lee Sandler - Officer | Option exercise | Common Stock | 5,000 | $7.80 | $39K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 2,237 | $93.85 footnote F2 | $210K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 2,263 | $94.75 footnote F3 | $214K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 500 | $95.47 footnote F4 | $48K | |
| Laura Lee Sandler - Officer | Option exercise | Employee Warrant (right to buy) | 5,000 | $0.00 | - | |
| ||||||
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 888 | $80.01 | $71K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 699 | $82.15 | $57K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 4,340 | $69.85 footnote F4 | $303K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 3,260 | $70.34 footnote F5 | $229K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 395 | $69.69 | $28K | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Employee Stock Option (right to buy) | 1,459 | $0.00 | - | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 1,459 | $34.39 | $50K | |
| Arjun Agarwal - Officer | Option exercise | Common Stock | 8,000 | $12.50 | $100K | |
| Arjun Agarwal - Officer | Open-market sale | Common Stock | 1,859 | $68.34 footnote F3 | $127K | |
| ||||||
| Joana Goncalves - Officer | Open-market sale | Common Stock | 1,636 | $68.38 footnote F3 | $112K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 5,064 | $69.42 footnote F4 | $352K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 300 | $70.62 footnote F5 | $21K | |
| Joana Goncalves - Officer | Open-market sale | Common Stock | 947 | $69.69 | $66K | |
| Joana Goncalves - Officer | Option exercise | Employee Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Joana Goncalves - Officer | Option exercise | Employee Warrant (right to buy) | 3,500 | $0.00 | - | |
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $7.80 | $27K | |
| Joana Goncalves - Officer | Option exercise | Common Stock | 3,500 | $6.84 | $24K | |
| ||||||
| Lawrence Otto Klein - Officer | Open-market sale | Common Stock | 1,729 | $69.69 | $120K | |
| Laura Lee Sandler - Officer | Open-market sale | Common Stock | 600 | $69.69 | $42K | |
| Paul T. Quinlan - Officer | Open-market sale | Common Stock | 733 | $69.69 | $51K | |
 Carl Dambkowski - Director | Open-market sale | Common Stock | 12,583 | $70.11 footnote F3 | $882K | |
| Carl Dambkowski - Director | Open-market sale | Common Stock | 22,417 | $70.13 footnote F2 | $1.57M | |
| ||||||
| Carl Dambkowski - Director | Grant or award | Stock Option (right to buy) | 9,136 | $0.00 | - | |
 Samarth Kulkarni - Director | Grant or award | Stock Option (right to buy) | 9,136 | $0.00 | - | |
| Christopher Nathan Martin - Director | Grant or award | Stock Option (right to buy) | 9,136 | $0.00 | - | |
| Kristine M. Ball - Director | Grant or award | Stock Option (right to buy) | 9,136 | $0.00 | - | |
Item 5.02, 9.01
Item 2.02, 9.01
Item 5.07
Item 8.01, 9.01
Recent ORKA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Arjun Agarwal | Officer | 9,999 | $821K | View on EDGAR | |
| LAWRENCE KLEIN | Director, Officer | 25,000 |
ORKA insider trading FAQ
What is the latest insider trade for ORKA?
Oruka Therapeutics, Inc. (ORKA) had 15 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for ORKA runs to 56 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ORKA stock?
No insider purchases of ORKA were filed in the last 90 days.
How many insiders are selling ORKA stock?
45 insider sales of ORKA were filed in the last 90 days, totaling $20.80M.
Where can I see ORKA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ORKA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Arjun Agarwal view on EDGAR
- - Lawrence Otto Klein view on EDGAR
- - Arjun Agarwal view on EDGAR
- - Paul T. Quinlan view on EDGAR
- - Joana Goncalves view on EDGAR
- - Arjun Agarwal view on EDGAR
- - Lawrence Otto Klein view on EDGAR
- - Paul T. Quinlan view on EDGAR
- - Laura Lee Sandler view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ORKA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ORKA with a 7-day demo
- ORKA on your watchlist
- Every ORKA Form 4 filing on record
- Up to 3 months of ORKA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
